Navigation Links
Global Hospital Infection Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast- 2018
Date:7/20/2014

Albany, New York (PRWEB) July 20, 2014

Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours. These conditions are also known as nosocomial infections. The causative agents of nosocomial infections include various types of microorganisms such as bacteria (Gram-positive and Gram-negative), viruses and fungi. The most common form of pathogens known to cause infections are superbugs such as staphylococcus aureus, escherichia Coli, enterococcus species, pseudomonas aeruginosa and klebshiella pneumonia, etc. Infections of surgical wounds, urinary tract infections and lower respiratory infections are the most common nosocomial infections. These pathogens have a high degree of resistance to antibiotic treatments. The common sources of nosocomial infection pathogens are contaminated air, water, food and medicine, used instruments and bio- medical wastes.

Request for customization of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1280

According to the WHO over 1.4 million people worldwide suffer from nosocomial infection related complications. The major factors influencing the development of nosocomial infections account for the healthcare settings, age, immune status and disease diagnostics and therapeutic interventions. Increasing resistance of the causative agents to antibiotics and the emerging new strains prove to be a crucial factor impacting the hospital infection therapeutic market. The emerging trend to treat nosocomial infections includes combination therapies which comprises of administration of antibiotics effective against superbugs. Some of the examples of emerging antibiotics are imipenem/cilastatin, combination is used against ESBL (extended spectrum ß- Lactamases) producing E.coli and Klebsheilla species. Ceftaroline, fifth generation cephalosporin is effective against multi drug resistant gram positive bacteria.

Rigorous research and development, use of combination therapies, increased awareness about nosocomial infections and its impacts, development of new drugs drive the hospital acquired therapeutic market and holds potential growth conditions. Geographically, North America leads this market followed by Europe. However increase in the development of healthcare infrastructure in emerging economies will lead to growth in demand for hospital infection therapeutics in Asia-Pacific and other parts of the world. Some of the major players in this market include Abbott Laboratories, Bayer Healthcare Pharmaceuticals, GlaxoSmithKline, Daiichi Sankyo, Pfizer and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

Early buyers will receive 10% customization on this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1280

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

Contact:
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA/Canada Toll Free: 866-552-3453
Email: sales(at)transparencymarketresearch(dot)com
More reports on: https://www.linkedin.com/today/author/73190868

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029185.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. R&D Key to Peracetic Acid Market Growth Globally Says a New Research Report Available at RnRMarketResearch.com
2. KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.
3. Global Point of Care Diagnostics Market: Industry Analysis, Size, Share, Growth and Forecast 2018
4. 2014QuinceaneraDresses.com: Beautiful Lace Quinceanera Dresses For The Global Market
5. 2014 Black Prom Dresses from BellasDress are Popular in the Global Market for their Elegance and Availability
6. Global Diagnostic Imaging Market: Industry Size, Share, Analysis and Forecasts 2018
7. Global and Chinese beta-Carotene Industry (CAS 7235-40-7) 2009-2019 Market Research Report Now Available at ReportsnReports.com
8. Global Breast Imaging Market (Ionizing, Non-Ionizing Technologies) Analysis in New Research Report Available at LifeScienceIndustryResearch.com
9. Global Epilepsy Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast 2019
10. Growing Consumption of Poultry Meat Drives the Global Choline Chloride Market, According to an Upcoming Report by Global Industry Analysts, Inc.
11. Focus on Health & Well-Being Drives the Whole Grain and High Fiber Foods Market, According to an Upcoming Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been ... (SLMBNI), part of Saint Luke’s Health System . Dr. Upadhyaya has served in ... M.Sc., FAANS joins Stanley P. Fisher, M.D., who has served as medical ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health ... Mental Health Services Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. ... Services, will facilitate the development of a hub and spoke model for opioid ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... total in scholarship awards to be awarded annually to and divided between two ... interest in bringing awareness to Amazonian plant medicine. To apply for the scholarship, ...
(Date:7/24/2017)... CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... and financial organizations, today announced it has partnered with WALLIX to expand ... Special Publication 800-171 . , There are a number of ways to address the ...
(Date:7/24/2017)... ... ... shows that, although people are taking more steps to protect themselves from sunburn, half of ... of sunburn within the past year. It’s common and people have been dealing with them ... have people become conscientious of the risks that accompany sunburns. , The team at ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized ... Arrays (SSA) for the fourth year in a row. 1 ... "Vendors in the Leaders quadrant have the highest scores for ... in the Leaders quadrant has the market share, credibility, and ... new technologies. These vendors demonstrate a clear understanding of market ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. , ... UTHR ) announced today that it will ... market opens on Thursday, July 27, 2017. ... teleconference on Thursday, July 27, 2017, at 9:00 a.m. ... with international callers dialing 1-970-315-0533.  A rebroadcast of the ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
Breaking Medicine Technology: